Member Info for Laura2022

Now 0 8p bid : )

Don't listen to grinch

Good morning iano

Thanks for that information

Dr Sargent has also been Head of Business Development for the UK's National Institute for Health and Care Research (NIHR), leading a team supporting global life science businesses access to funding and research infrastructure in the UK.

Totally in unison with your comments TIO

Don't people simply report then filter

Or contact info@lse.co.uk and they are swift to act , particularly if many genuine holders do that

They always respond within 24hrs

Well.spotted Croissant

2023

The UK is rejoining the EU’s flagship funding scheme for scientific research, Prime Minister Rishi Sunak confirmed today. 

For the first time since Brexit, scientists and research institutes in the UK will now be able to apply for money from the £81bn (€95bn) Horizon Europe fund, the world’s largest research collaboration programme. 

Michelle Mitchell, Cancer Research UK’s chief executive, welcomed the announcement. 

“Horizon Europe association is overwhelmingly in the best interests of cancer patients and scientists, and it is great news for cancer research that agreement has finally been reached between the UK and EU,” she said. 

Thanks Debull

Horizon is the big one, which is what Conservatives rejoined for first time since Brexit

Think UK re entered Horizon funding in 2023

European innovation grants (EUREKA, HORIZON, EIC, etc)

Https://www.beyondblood.co/copy-of-technology-1

Very exciting for BB/PYC given the labour Gov commitment to spending £500mln+ to UK life science companies

Ministers and Medical Miracles Unite! 🤝

This week, we had the pleasure of welcoming the MedTech Innovation Directorate and Policy Adviser from the Department of Health and Social Care (DHSC) and the Department for Science, Innovation and Technology (DSIT) to Beyond Blood Diagnostics.

Our research powerfully supports the UK Government's initiatives in enhancing early disease detection, reducing waiting times, and driving innovation in point-of-care diagnostics — aligning with national goals to improve patient care efficiency, expedite clinical trials, and support integrated care models.

Innovation and collaboration are at the heart of our mission! 💼

Still hope?

. Until the additional capital is secured, the group will continue to proceed by utilising existing cash reserves and drawing on the CLN facility. The board will not commit to significant further capital expenditure until the full finance package is in place to complete the rebuild.”

But in an upbeat note it added: “The board intends that the group is able to operate as a going concern for the foreseeable future. Consequently, the board continues to adopt the going concern basis in preparing these financial statements despite the material uncertainty referred to above.”

Thanks Trench

Have you got a link please

At the date of this report, there is not currently any formal commitment from the existing or new noteholders to purchase any Tranche G notes. If the Group fails to find purchases for the Tranche G notes, then, in absence of other new sources of finance, it is anticipated it would no longer be able to meet its liabilities as they fall due from January 2025.

True colours now Neil777 amd your other IDs before you created Santa 3 weeks ago

Tragic

I assume the green box is the disruptor from the weekend

Just report and filter dandy

Many here are eying much further than 1p /£1.6mln cap

Lse now showing

Another good start to 2025

500k, 330k, 200k

https://www.londonstockexchange.com/stock/PYC/physiomics-plc/company-page